Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Nov 18, 2016
Financial News
Spring Bank completes private placement of common stock and warrants
...through the sale of 1.6 million shares at $9.12 in a private placement led by
MPM Oncology Impact Fund
...
Read More
BioCentury
|
Jun 6, 2016
Financial News
argenx completes private placement
...EUR30 million ($33.4 million) Shares: 2.7 million Price: EUR11.10 Shares after offering: 20 million Investors:
MPM Oncology Impact Fund
...
Read More
BioCentury
|
Jun 4, 2016
Financial News
argenx raises EUR 30 million
...the day before it announced the deal. Investors included Aquilo Capital, Burrage Capital, Dafna Capital,
MPM Oncology Impact Fund
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Nov 18, 2016
Financial News
Spring Bank completes private placement of common stock and warrants
...through the sale of 1.6 million shares at $9.12 in a private placement led by
MPM Oncology Impact Fund
...
Read More
BioCentury
|
Jun 6, 2016
Financial News
argenx completes private placement
...EUR30 million ($33.4 million) Shares: 2.7 million Price: EUR11.10 Shares after offering: 20 million Investors:
MPM Oncology Impact Fund
...
Read More
BioCentury
|
Jun 4, 2016
Financial News
argenx raises EUR 30 million
...the day before it announced the deal. Investors included Aquilo Capital, Burrage Capital, Dafna Capital,
MPM Oncology Impact Fund
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page